Physician profile
Kanika A Bowen-Jallow
NPI 1760686364
$4,641.88
in general payments reported to CMS, 2019-2025
13 companies · $1,245 in 2025
The $1,245 reported for 2025 was more than what 85% of Pediatric Surgery providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,717 · 2020: $15.34 · 2021: $1,032 · 2022: $29.69 · 2023: $410 · 2024: $193 · 2025: $1,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210 · Travel and Lodging: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.27 |
| Travel and Lodging | $636.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,671.78 | 2019 | |
| Medtronic, INC. | $1,148.97 | 2023-2025 | Signia, Ligasure, Gia |
| Intuitive Surgical, INC. | $874.88 | 2021-2023 | Da Vinci Surgical System |
| Bolder Surgical LLC | $319.09 | 2019-2021 | |
| Baxter Healthcare | $265.06 | 2023-2025 | Tisseel, Perclot |
| Hologic Sales and Service, LLC | $115.44 | 2024 | Coolseal Generator |
| Teleflex LLC | $104.44 | 2025 | Titan Sgs Bailout Chuck |
| Bolder Surgical, LLC | $29.69 | 2022 | |
| Conmed Corporation | $29.66 | 2023 | Airseal |
| Cumberland Pharmaceuticals, INC. | $28.07 | 2024 | Caldolor |
| Cook Biotech Incorporated | $21.58 | 2023 | Fortify Flowable |
| Reshape Lifesciences INC. | $17.88 | 2019 | |
| Neurocrine Biosciences, INC. | $15.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanika Bowen-Jallow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.